Clinical Trial Update: Post-Market BTVA Registry

View source ↗

Summary

Post-market registry trial evaluating bronchoscopic thermal vapor ablation (BTVA) for emphysema or chronic obstructive pulmonary disease is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: Uptake Medical Technology, Inc. | Conditions: Emphysema or COPD | Status: RECRUITING